The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05977-8 ↗At a glance
Journal article in World Journal of Urology, 2025. Written by Francesco Guzzi and 14 co-authors. Institution: Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy. Major MEDLINE topics: Prostatectomy, Prostatic Neoplasms, Neoplasm Recurrence, Local, Prostatitis. Cited 2 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Università di Foggia.
Abstract (original language)
Background
Inflammatory processes are thought to contribute to the development and progression of prostate cancer (PCa). This study aimed to evaluate whether a novel Prostatic Inflammation Score (PIS), integrating Irani Grade (G) and Aggressiveness (A), could predict the risk of biochemical recurrence (BCR) following radical prostatectomy (RP).
Methods
Patients undergoing biopsy and RP between 2013 and 2023 were included. PIS was assessed on hematoxylin and eosin-stained biopsy cores: PIS 1 (G 0–1/A 0–1), PIS 2 (G 2–3/A 0–1), and PIS 3 (G 0–3/A 2–3). BCR, considered as two consecutive PSA readings of ≥ 0.2 ng/mL, was evaluated through multivariable Cox regression analysis.
Results
Among 679 patients (median follow-up: 36 months), 127 (18.7%) experienced BCR. Over a median follow-up of 36 months, 127 (18.7%) patients experienced BCR. BCR incidence at six years was highest in PIS 1 (30%) vs. PIS 2 (10%) and PIS 3 (9%) ( p = 0.002). Compared to PIS 1, hazard ratios (HR) for BCR were 0.44 (95% CI: 0.27–0.74) for PIS 2 and 0.37 (95% CI: 0.15–0.91) for PIS 3. IRANI G scores inversely correlated with BCR risk (HR = 0.44, 95% CI: 0.27–0.74), while IRANI A scores (2–3) showed a nonsignificant trend (HR = 0.41, 95% CI: 0.17–1.02, p = 0.054). Gleason grade and pT stage were significantly associated with BCR, while margin status and pN stage were not.
Conclusions
PIS 1 was found to be associated with BCR after RP. Should these findings be externally validated, PIS could represent a readily available inexpensive tool to predict BCR after RP.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy.
- Department of Urology and Renal Transplantation, Policlinico Foggia, University of Foggia, 71122, Foggia, Italy. ugofalagario@gmail.com.
- Department of Molecular Medicine and Surgery, (Solna), Karolinska Institutet, Stockholm, Sweden. ugofalagario@gmail.com.
- Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
- Department of Urology, Bonomo Teaching Hospital, 76123, Andria, Italy.
- Urology Unit, Azienda Ospedaliero-Universitaria delle Macrhe Università Politecnica Delle Marche, Via Conca 71, 60126, Ancona, Italy.
Funding
- Università di Foggia
Cite
APA
Guzzi, F., Falagario, U. G., Cormio, A., Ninivaggi, A., Finati, M., d'Altilia, N., Fanelli, A., Fiorella, R. A., Busetto, G. M., Bettocchi, C., Castellani, D., Conteduca, V., Carrieri, G., Sanguedolce, F., & Cormio, L. (2025). The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy. World Journal of Urology. https://doi.org/10.1007/s00345-025-05977-8
Vancouver
Guzzi F, Falagario UG, Cormio A, Ninivaggi A, Finati M, d'Altilia N, et al. The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy. World Journal of Urology. 2025. doi:10.1007/s00345-025-05977-8
BibTeX
@article{Guzzi2025,
author = {Guzzi, Francesco and Falagario, Ugo Giovanni and Cormio, Angelo and Ninivaggi, Antonella and Finati, Marco and d'Altilia, Nicola and Fanelli, Antonio and Fiorella, Ruggiero Antonio and Busetto, Gian Maria and Bettocchi, Carlo and Castellani, Daniele and Conteduca, Vincenza and Carrieri, Giuseppe and Sanguedolce, Francesca and Cormio, Luigi},
title = {The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05977-8}
}
EUVIMED